Cooperative Agreement 2604163
- Federal Cooperative Agreement Summary X-Sight Incorporated received $1.25M in funding from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) under an SBIR Phase II award, effective June 15, 2025, with completion targeted for May 31, 2027. The award supports the development of compact, distributed multi-source X-ray imaging technology designed to replace conventional mechanically-rotating computed tomography (CT) systems. The core deliverable...
- Federal Cooperative Agreement Award Summary Adialante L.L.C. received a $1.19M Small Business Innovation Research (SBIR) Phase II award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on June 15, 2025, with completion anticipated by November 30, 2026. The award supports the commercialization and development of an innovative head-only Magnetic Resonance Imaging (MRI) scanner platform designed to deliver clinical-quality brain imaging...
- Federal Cooperative Agreement Summary Abstractive Health, Inc. received a $1.25 million Small Business Innovation Research (SBIR) Phase II Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 1, 2025, through June 30, 2027. The awardee will develop and refine a machine learning-enabled software tool that leverages natural language processing (NLP) to automatically generate clinically relevant...
- Federal Cooperative Agreement Summary Award Details: Illuminant Surgical Inc. received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on August 15, 2025, for the SBIR Phase II project titled "Novel Camera-Projector Device Leveraging Non-Invasive Registration and Projected Augmented Reality for Navigation in Minimally Invasive Spine Procedures." The project extends through...
- Federal Cooperative Agreement Summary Asterion AI Inc. received a $1.25 million Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084), effective August 1, 2025 through July 31, 2027. The awardee will develop and validate an electroencephalogram (EEG)-based software product designed for pre-hospital stroke triage and detection of large vessel occlusion (LVO) strokes. The deliverables include expansion of a...
- Federal Cooperative Agreement Summary Foresightcares Inc., a minority-owned and woman-owned small business based in Matthews, North Carolina, received a $1.23 million Small Business Innovation Research (SBIR) Phase II Cooperative Agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084). The award, dated September 15, 2025, with completion targeted for August 31, 2027, funds development of an artificial intelligence-based...
- Federal Cooperative Agreement Summary AI Linear Inc. was awarded $1.25 million through the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on July 15, 2025, for an SBIR Phase II project with completion targeted for June 30, 2027. The awardee will develop an artificial intelligence (AI)-enabled integrated circuit (IC) designed for real-time anomaly detection in predictive maintenance applications. The IC combines an ultra-low-power analog...
- Federal Cooperative Agreement Summary Sentire Medical Systems, Inc. received a $1,189,332 Small Business Technology Transfer (STTR) Phase II Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), awarded June 15, 2025, with a completion date of May 31, 2027. The awardee is developing an intraoperative monitoring device utilizing gas-based sensing technology to detect inadvertent bowel injuries during minimally...
- Cooperative Agreement Award Summary Echo Mind AI Corp. received a $1.25 million Cooperative Agreement award dated July 15, 2025, from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to develop artificial intelligence (AI)-enabled ultrasound technology for musculoskeletal (MSK) injury imaging and diagnosis. The project, which extends through June 30, 2027, focuses on creating AI-powered guidance systems that enable novice...
- Federal Cooperative Agreement Summary Freescale LLC (doing business as Neuraink) received a $1.24 million Phase II Small Business Innovation Research (SBIR) Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), awarded September 15, 2025, with completion targeted for August 31, 2027. The award funds the development and commercialization of a proprietary multifunctional printing platform that deposits conductive,...
Neuraltrak, Inc. received a $1.25 million Small Business Innovation Research (SBIR) Phase II cooperative agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), awarded June 15, 2026, with completion targeted for May 31, 2028. The awardee will develop and clinically validate artificial intelligence-powered software technology that enables standard mobile surgical X-ray systems to generate high-quality three-dimensional computed tomography (CT) images. The solution addresses the technical limitation that conventional mobile imaging systems produce primarily two-dimensional images due to their limited rotation angle and radiation dose constraints, making it difficult to fully visualize surgical anatomy and implanted hardware during procedures. The primary deliverable is a software-based imaging solution that upgrades existing widely deployed mobile X-ray equipment rather than requiring hospitals to purchase expensive dedicated CT scanners. This approach supports scalable commercialization across surgical centers while delivering significant healthcare value through reduced procedure time, lower radiation exposure, decreased complication rates, and improved patient safety—particularly for spine operations and other procedures performed in outpatient surgical centers and community hospitals. The technology is expected to expand access to advanced three-dimensional surgical imaging in underserved regions and support broader national competitiveness in medical imaging innovation.Federal Cooperative Agreement Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 6/3/26 |